
1st Phorm’s ‘110% Money-Back Guarantee’
Money-back guarantee comes up woefully short of advertised percentage.
Lehr et al. v. Cryo-Cell International, Inc.
23-cv-80405, S.D. Fla.
(Jan. 2023)
Umbilical cord blood banking program
Deceptively marketing that stored cord blood can treat at least 80 serious medical conditions without disclosing that the FDA has approved the use of cord blood to treat only 7 medical conditions and that the odds of being able to use cord blood for treatment is “virtually zero”
Pending
Money-back guarantee comes up woefully short of advertised percentage.
Is it still a guarantee if it has strings attached?
Lawsuits allege “100%” marketing on front label is misleading.
TINA.org reader was charged a lot more than the advertised price. He’s not alone.
TINA.org explores the divide between the marketing and the science.